scispace - formally typeset
A

Arti Parekh

Researcher at Johns Hopkins University

Publications -  24
Citations -  763

Arti Parekh is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Androgen deprivation therapy & Prostate cancer. The author has an hindex of 10, co-authored 22 publications receiving 647 citations. Previous affiliations of Arti Parekh include Brigham and Women's Hospital & Harvard University.

Papers
More filters
Journal ArticleDOI

Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer: A Meta-analysis of Randomized Trials

TL;DR: A systematic review and meta-analysis of randomized trials to determine whether androgen deprivation therapy (ADT) is associated with cardiovascular mortality, prostate cancer-specific mortality (PCSM), and all-cause mortality in men with unfavorable-risk, nonmetastatic prostate cancer was performed in this article.
Journal ArticleDOI

Refusal of curative radiation therapy and surgery among patients with cancer.

TL;DR: Nonwhite, less affluent, and unmarried patients are more likely to refuse curative surgical and/or radiation-based oncologic therapy, raising concern that socioeconomic factors may drive some patients to forego potentially life-saving care.
Journal ArticleDOI

Cancer Control and Complications of Salvage Local Therapy After Failure of Radiotherapy for Prostate Cancer: A Systematic Review

TL;DR: 5-year biochemical control rates to be similar across treatments, in the range of 52%-56%, although patient selection and definition of failure was variable, and Toxicity profiles were also distinct between local salvage modalities.

Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer.

TL;DR: Maximal bowel displacement with IMRT yields favorable acute GI toxicity and pathologic downstaging profiles, as compared to 3D-CRT in preoperative CRT for rectal cancer and warrants further prospective investigation.
Journal ArticleDOI

Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: Role of fractionation and treatment volume.

TL;DR: The findings highlight the need to explore the use of less toxic hypofractionated regimens in patients who are at the highest risk of acute skin toxicity, including those with a higher BMI and those receiving PMRT.